Foam Inhibitors Portfolio
Shrieve's Progiline® FI Range of High-Performance Foam Inhibitors
PROGILINE® FI technology works by mimicking the molecules contained in the bubbles that make up the foam. When PROGILINE® FI is introduced into the system, its molecules line up with the naturally occurring ones within the bubble wall. However, because the FI molecules are not structurally identical to the foam-causing surfactants, they destabilize the bubble wall, ultimately causing the foam to break down.
The PROGILINE® FI range of foam inhibitors are highly specific, active products that minimize dosage rates in their given application. PROGILINE® FI has demonstrated up to 60% treat-rate reduction compared with other available products. The specific design of PROGILINE® FI molecules creates a significant performance benefit of the products offering both anti-foaming and defoaming capability, increasing efficiency in the intended application at required operational temperatures. They effectively reduce problems with air, surface foaming, and flaws caused by bubbles.
Using PROGILINE® FI will help to lower overall foam control adjuvant inventory and lead to a more simplified and efficient supply chain.